ABT will soon launch an IgM COVID-19 lab-based serology test to complement the IgG test launched yesterday. ABT is also working on a lateral-flow point-of-care COVID-19 serology test. Source: 1Q20 CC today.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”